The landmark REDUCE-IT trial demonstrated that icosapent ethyl (IPE) 4 g daily significantly reduced cardiovascular events in high-risk patients when added to statin therapy, but is a fancy fish oil supplement really worth our coin?

Guest Authors:  Joseph Nardolillo, PharmD, BCACP and Vivian Cheng, PharmD, BCPS, BCACP

Music by Good Talk